A federal judge allowed the Drug Enforcement Administration to suspend Cardinal Health's license to ship controlled substances from its distribution center in Lakeland, Fla.
Judge allows DEA hold on Cardinal Health drug shipments
Cardinal Health had filed a motion for a preliminary injunction against the DEA's suspension of its drug distributor's license on Feb. 6 in U.S. District Court in Washington.
The Dublin, Ohio-based company said in a statement (PDF) that it disagreed with Judge Reggie Walton's Feb. 29 decision and that it plans to appeal the ruling.
“We have genuine respect for the work of the DEA, but effectively addressing prescription drug abuse requires a very different approach than does the war on illicit drugs,” Cardinal Health said in the statement.
On Feb. 6, the DEA issued immediate suspension orders to Cardinal Health and two CVS/Pharmacy facilities in Sanford, Fla., both of which are customers of Cardinal Health, according to a DEA news release.
The agency alleges that Cardinal Health “failed to maintain effective controls against the diversion of controlled substances” and that it “failed to conduct due diligence to ensure that the controlled substances were not diverted into other than legitimate channels.”
The DEA said the average pharmacy in the U.S. ordered 69,000 oxycodone dosage units last year, while the two CVS/Pharmacy sites ordered about three million dosage units.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.